You are here

  • Fontelo P. Can journal abstracts alone be used for clinical decision making [Letter]? BMJ. 2011 Nov 2.
  • Zarin D, Tse T. Clarification about ClinicalTrials.gov [Letter]. IRB. 2013 May-Jun;35(3):19.
  • Zarin D. Factual Errors about ClinicalTrials.gov and other federal mandates in special report by Shuster [Letter]. Clin Transl Sci. 2012 Apr;5(2):217; author reply 217. doi: 10.1111/j.1752-8062.2012.00410.x.
  • Fallavollita P, Kersten M, Linte CA, Pratt P, Yaniv Z. Guest Editors' Foreword: Special Issue on Augmented Environments for Computer-Assisted Interventions CAI systems enable more precise, safer, and less invasive interventional treatments [Letter]. Healthc Technol Lett. 2017 Oct 27;4(5):149. doi: 10.1049/htl.2017.0078. eCollection 2017 Oct.
  • Altemus AR. Mobile App: Native Voices: Native Peoples' Concepts of Health and Illness
  • Fontelo P. Mobile App: PubMed for Handhelds.
  • Gill MJ, Pearson G, Neve L, Miernicki G, Antani SK, Thoma GR. Mobile App: ReUnite iOS app
  • Zarin D. Participant-level data and the new frontier in trial transparency [Letter]. N Engl J Med. 2013 Aug 1;369(5):468-9. doi: 10.1056/NEJMe1307268.
  • Zarin D, Tse T. The effect of funding source on outcome reporting among drug trials [Letter]. Ann Intern Med. 2011 Jan 18;154(2):137-8; author reply 138. doi: 10.7326/0003-4819-154-2-201101180-00020.
  • Zarin DA, Tse T. Tracking health services research studies [Letter]. JAMA. 2008 Nov 19;300(19):2252; author reply 2252. doi: 10.1001/jama.2008.612.
  • Zarin D, Tse T. Trust but verify: trial registration and determining fidelity to the protocol [Letter]. Ann Intern Med. 2013 Jul 2;159(1):65-7. doi: 10.7326/0003-4819-159-1-201307020-00011.
  • Zarin DA, Tse T. Unambiguous identification of obesity trials [Letter]. N Engl J Med. 2013 Feb 7;368(6):580-1. doi: 10.1056/NEJMc1215018.